Skip to main content
Kenvue10-K: Compliance burden

Key EU markets reclassify PSE products (Sudafed) to prescription-only, impacting sales channels

What happened

Belgium, Luxembourg, and France changing PSE products from Over-the-Counter to prescription-only disrupts existing sales models and revenue streams, requiring adjustments to distribution, marketing, and forecasting in the region.

Source

SEC EDGARFeb 20, 2026

Annual report (Form 10-K)

Kenvue 10-K for FY2025

Filing excerpt

During the fiscal twelve months ended December 29, 2024, Belgium, Luxembourg, and France changed the regulatory status of medications containing PSE from OTC to prescription-only.

sec.gov/Archives/edgar/data/1944048/000194404826000030/kvue-20251228.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Compliance burden

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/28
Filed
Feb 20, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
1944048
Accession number
0001944048-26-000030
Timeframe
Current year
Filing year
2026
Why it matters
GRC tools needed
Signal category
Risk

Topics and mentions

Regions named

  • EMEA

Extraction

Confidence
High
Relevance
70%
Sentiment
Negative
Detected
Feb 24, 2026
signal_type
sec-10k
signal_subtype
complianceBurden

Use this data

Get every 10-K signal for Kenvue and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Kenvue this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1c05dd53-9b43-45eb-8950-160dbea20c6a returns this record as JSON. POST /v1/companies/enrich returns every signal for kenvue.com.

{
  "signal_id": "1c05dd53-9b43-45eb-8950-160dbea20c6a",
  "signal_type": "sec-10k",
  "signal_subtype": "complianceBurden",
  "detected_at": "2026-02-24T09:25:34.306+00:00",
  "company": {
    "name": "Kenvue",
    "domain": "kenvue.com"
  },
  "data": {
    "detail": "Belgium, Luxembourg, and France changing PSE products from Over-the-Counter to prescription-only disrupts existing sales models and revenue streams, requiring adjustments to distribution, marketing, and forecasting in the region.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Key EU markets reclassify PSE products (Sudafed) to prescription-only, impacting sales channels",
    "excerpts": "During the fiscal twelve months ended December 29, 2024, Belgium, Luxembourg, and France changed the regulatory status of medications containing PSE from OTC to prescription-only.",
    "relevance": 0.7,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1944048/000194404826000030/kvue-20251228.htm",
    "filing_date": "2026-02-20",
    "filing_year": 2026,
    "fiscal_year_end": "12/28",
    "sales_relevance": "GRC tools needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "EMEA"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.